CI
AGN

Constellation Investments’s Allergan Inc AGN Stock Holding History

Constellation Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,000
Closed -$1.28M – 435
2014
Q4 		$1.28M Buy
6,000
+200
+3% +$39.8K 0.26% 89
2014
Q3 		$1.03M Buy
5,800
+100
+2% +$16.6K 0.23% 99
2014
Q2 		$965K Buy
5,700
+100
+2% +$15.6K 0.22% 104
2014
Q1 		$695K Buy
5,600
+100
+2% +$12.2K 0.17% 139
2013
Q4 		$611K Buy
5,500
+400
+8% +$38.2K 0.16% 158
2013
Q3 		$461K Buy
5,100
+300
+6% +$26.9K 0.14% 176
2013
Q2 		$404K Buy
+4,800
New +$498K 0.14% 174

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Constellation Investments's AGN Position: Q1 2015 in Review

Constellation Investments sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 6,000 shares — an estimated $1.28M sold.

Constellation Investments first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.28M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Constellation Investments reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Constellation Investments sold 6,000 Allergan Inc shares in Q1 2015, an estimated $1.28M.
  • Constellation Investments first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Constellation Investments's Allergan Inc position peaked at $1.28M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Constellation Investments's 13F filing for Q1 2015, filed 13 May 2015.